Efficacy of once-daily indacaterol relative to alternative bronchodilators in COPD: A patient-level mixed treatment comparison

Value in Health

Volumn 15, Issue 3, 2012, Pages 524-533

  Cope, Shannon ^a   Capkun Niggli, Gorana ^b   Gale, Rupert ^c   Lassen, Cheryl ^c   Owen, Roger ^c   Ouwens, Mario J N M ^d   Bergman, Gert ^d   Jansen, Jeroen P ^a  

^a MAPI Consultancy   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c NOVARTIS HORSHAM RESEARCH CENTRE   (United Kingdom)

^d MAPI GROUP   (Netherlands)

Author keywords

chronic obstructive pulmonary disease; indacaterol; individual patient data; mixed treatment comparison

Indexed keywords

FORMOTEROL; INDACATEROL; SALMETEROL; TIOTROPIUM BROMIDE;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE EFFECTIVENESS; DRUG EFFICACY; FORCED EXPIRATORY VOLUME; HUMAN; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ST GEORGE RESPIRATORY QUESTIONNAIRE; TRANSITION DYSPNEA INDEX; TREATMENT OUTCOME;

BAYES THEOREM; BRONCHODILATOR AGENTS; ENDPOINT DETERMINATION; FEMALE; HUMANS; INDANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; QUINOLONES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84861156913     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2012.01.009     Document Type: Article

References (42)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global strategy for the diagnosis, management and prevention of COPD http://www.goldcopd.org/uploads/users/files/GOLD-Report-2011-Feb21.pdf 2011 [Accessed February 1, 2011]
2. European Medicines Agency Onbrez Breezhaler indacaterol Doc. Ref.: EMA/625202/2009 2010 http://www.ema.europa.eu/docs/en-GB/document-library/EPAR- Summary-for-the-public/human/001114/WC500053733.pdf [Accessed February 1, 2011]
3. 2-agonist indacaterol versus twice-daily formoterol in COPD Thorax 65 2010 473 479
4. J.F. Donohue, C. Fogarty, J. Lotvall Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium Am J Respir Crit Care Med 182 2010 155 162
5. O. Kornmann, R. Dahl, S. Centanni Once-daily indacaterol vs twice-daily salmeterol for COPD: a placebo-controlled comparison Eur Respir J 37 2011 273 279
6. G. Feldman, T. Siler, N. Prasad Efficacy and safety of indacaterol 150 μg once-daily in COPD: a double-blind, randomised, 12-week study BMC Pulm Med 10 2010 11
7. H.J. Schünemann, A.D. Oxman, G.E. Vist et al. Interpreting results and drawing conclusions J.P.T. Higgins, S. Green, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011) 2011 The Cochrane Collaboration www.cochrane-handbook.org [Accessed December 1, 2011]
8. G. Lu, A.E. Ades Combination of direct and indirect evidence in mixed treatment comparisons Stat Med 23 2004 3105 3124 (Pubitemid 39334902)
9. J.P. Jansen, B. Crawford, G. Bergman, W. Stam Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons Value Health 11 2008 956 964
10. P.W. Jones St. George's Respiratory Questionnaire: MCID COPD 2 2005 75 79 (Pubitemid 40776227)
11. T.J. Witek Jr., D.A. Mahler Minimal important difference of the transition dyspnoea index in a multinational clinical trial Eur Respir J 21 2003 267 272 (Pubitemid 36204541)
12. J.P. Jansen, R. Fleurence, B. Devine Interpreting indirect treatment comparisons & network meta-analysis for health care decision-making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices - Part 1 Value Health 14 2011 417 428
13. A.E. Ades A chain of evidence with mixed comparisons: models for multi-parameter synthesis and consistency of evidence Stat Med 22 2003 2995 3016 (Pubitemid 37160601)
14. D.M. Caldwell, A.E. Ades, J.P. Higgins Simultaneous comparison of multiple treatments: combining direct and indirect evidence BMJ 331 2005 897 900 (Pubitemid 41502718)
15. D.C. Hoaglin, N. Hawkins, J.P. Jansen Conducting indirect treatment comparison and network meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices - Part 2 Value Health 14 2011 429 437
16. A.J. Sutton, K.R. Abrams, D.R. Jones Methods for Meta-Analysis in Medical Research 2000 Wiley Chichester, UK
17. D. Spiegelhalter, K. Abrams, J. Myles Bayesian Approaches to Clinical Trials and Health Care Evaluation 2004 Wiley Chichester, UK
18. N.J. Cooper, A.J. Sutton, D. Morris Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation Stat Med 28 2009 1861 1881
19. A.P. Dempster The direct use of likelihood for significance testing Stat Comput 7 1997 247 252 (Pubitemid 128000163)
20. D.J. Spiegelhalter, N.G. Best, B.P. Carlin, A. van der Linde Bayesian measures of model complexity and fit J R Stat Soc Series B Stat Methodol 64 2002 583 639
21. S.P. Brooks, A. Gelman General methods for monitoring convergence of iterative simulations J Comput Graph Stat 7 1998 434 455 (Pubitemid 128635035)
22. R. Casaburi, D.D. Briggs, J.F. Donohue The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial Chest 118 2000 1294 1302
23. R. Casaburi, D.A. Mahler, P.W. Jones A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease Eur Respir J 19 2002 217 224 (Pubitemid 34162820)
24. J.F. Donohue, J.A. van Noord, E.D. Bateman A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol Chest 122 2002 47 55 (Pubitemid 34754142)
25. P.M. Calverley, A. Lee, L. Towse Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease Thorax 58 2003 855 860 (Pubitemid 37239232)
26. M.R. Partridge, N. Karlsson, I.R. Small Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey Curr Med Res Opin 25 2009 2043 2048
27. B.R. Celli, C.G. Cote, J.M. Marin The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease N Engl J Med 350 2004 1005 1012 (Pubitemid 38269277)
28. M. Cazzola, W. MacNee, F.J. Martinez Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur Respir J 31 2008 416 469
29. R. Dahl, L.A. Greefhorst, D. Nowak Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 2001 778 784 (Pubitemid 32881913)
30. A. Rossi, P. Kristufek, B. Levine Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD Chest 121 2002 1058 1069 (Pubitemid 34280423)
31. J.A. van Noord, J.L. Aumann, E. Janssens Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD Eur Respir J 26 2005 214 222 (Pubitemid 41079064)
32. W.L. Baker, E.L. Baker, C.I. Coleman Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis Pharmacotherapy 29 2009 891 905
33. M.A. Puhan, L.M. Bachmann, J. Kleijnen Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis BMC Med 7 2009 2
34. J. Bourbeau, S.J. Bartlett Patient adherence in COPD Thorax 63 2008 831 838
35. L.M. Campbell Once-daily inhaled corticosteroids in mild to moderate asthma: improving acceptance of treatment Drugs 58 Suppl. 4 1999 25 33 (Pubitemid 30192630)
36. G. Tamura, K. Ohta Adherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patch Respir Med 101 2007 1895 1902 (Pubitemid 47163538)
37. S. Greenland A review of multilevel theory for ecologic analyses Stat Med 21 2002 389 395 (Pubitemid 34144649)
38. R.D. Riley, P.C. Lambert, J.A. Staessen Meta-analysis of continuous outcomes combining individual patient data and aggregate data Stat Med 27 2008 1870 1893 (Pubitemid 351634244)
39. C. Jackson, N. Best, S. Richardson Improving ecological inference using individual-level data Stat Med 25 2006 2136 2159 (Pubitemid 43950284)
40. C. Jackson, N. Best, S. Richardson Hierarchical related regression for combining aggregate and individual data in studies of socio-economic disease risk factors J Royal Stat Soc (A) 171 2008 159 178
41. M.D. Begg, M.K. Parides Separation of individual-level and cluster-level covariate effects in regression analysis of correlated data Stat Med 22 2003 2591 2602 (Pubitemid 36974582)
42. J.M. Neuhaus, J.D. Kalbfleisch Between- and within-cluster covariate effects in the analysis of clustered data Biometrics 54 1998 638 645 (Pubitemid 28262485)